Remodeling of the left atrium in patients with 4-5 stage chronic kidney disease


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Purpose of the study. To investigate clinical and functional aspects of the left atrial remodeling in patients with stage 4-5 of the chronic kidney disease (CKD). Materials and methods. A total of 172 patients with CKD stage 4-5 at aged 16-74 years, were examined. Depending on the anterior-posterior size of the left atrium (LA) in diastole, all examined individuals (n = 172) were divided into two groups: 1st - individuals with CKD and normal size (less than 4.0 cm) of the LA (n = 126), 2nd - patients with CKD and increased anterior-posterior size (more than 4.0 cm) of the LA (n = 46). General physical examination and transthoracic echocardiography with the definition of the LA index in diastole was performed. Results. Statistically significant increase in the end systolic (4.20 ± 0.65 cm vs. 3.55 ± 0.47 cm, p < 0.01) and diastolic dimensions (5.97 ± 0.55 cm vs. 5,38 ± 0,43 cm, p < 0.01), thickness of interventricular septum (1,17 ± 0,16 cm vs 0,99 ± 0,14 cm, p < 0.01) and left ventricular posterior wall (1,13 ± 0.15 cm vs 0.97 ± 0.13 cm, p < 0.01) compared to CKD patients with normal size (less than 4.0 cm) of LA. In patients with left atrial dilatation, significantly higher values of the indexed mass of left ventricular myocardium (267 ± 62 g/m2 vs 198 ± 44 g/m2, p < 0.01) were registered. Eccentric type of the heart structural restructuring was significantly more often detected in the 1st group (87.3% vs 56.5%, p < 0.01) in comparison with the 2nd group. Frequency of the concentric type of left ventricular hypertrophy was significantly higher in the group with left atrial dilatation (43.5% vs 12.7%, p < 0.01) in comparison with the 1st group. In patients with CKD, left atrial dilatation was associated with a significant increase in the anterior - posterior dimension of the right ventricle (2.24 ± 0.47 cm vs 1.83 ± 0.37 cm, p < 0.01) and thickness of its anterior wall (0.41 ± 0.03 cm vs 0.39 ± 0.03 cm, p < 0.01). Patients of the 2nd group had higher body mass index values (25.5 ± 5.14 kg m vs 23.6 ± 3.91 kg/m, p < 0.01), systolic (168 ± 29 mm Hg vs 152 ± 27 mm Hg, p< 0.01) and diastolic (102 ± 20 mm Hg vs 94 ± 15 mm Hg, p < 0.01) arterial pressure, C-reactive protein (84.7% vs 20.6%, p < 0.01). Conclusion. In patients with at predialysis stage of CKD, left atrial remodeling is accompanied by increased levels of C-reactive protein and forming of concentric type of left ventricular hypertrophy.

全文:

受限制的访问

作者简介

I. Murkamilov

Kyrgyz State Medical Academy named after I.K. Akhunbaev; SEI HPE Kyrgyz Russian Slavic University; Chronic Kidney Disease Specialists Society of Kyrgyzstan

Email: murkamilov.i@mail.ru

Ph.D. (Med.), Acting Associate Professor of the Department of Faculty Therapy, Nephrologist; Chairman of the board

K. Aitbaev

Research Institute of Molecular Biology and Medicine; Chronic Kidney Disease Specialists Society of Kyrgyzstan

Email: murkamilov.i@mail.ru

Dr.Sc. (Med.), Professor, Head of Laboratory of Pathological Physiology; Board Member

Zh. Murkamilova

SEI HPE Kyrgyz Russian Slavic University

Email: murkamilovazh.t@mail.ru

Post-graduate Student, the Department of Therapy N2 of the specialty "General Medicine"

V. Fomin

Sklifosovsky Institute; FSAEI HE First Moscow State Medical University named after I.M. Sechenov

Email: fomin@mma.ru

Corresponding Member of RAS, Professor, Dr.Sc. (Med.), Head of the Department of Faculty Therapy No. 1; Vice-rector in Clinical Work and Continuous Professional Education

I. Kudaibergenova

Kyrgyz State Medical Academy named after I.K. Akhunbaev

Email: k_i_o2403@mail.ru

Dr.Sc. (Med.), Professor, Rector

F. Yusupov

Osh State University; Chronic Kidney Disease Specialists Society of Kyrgyzstan

编辑信件的主要联系方式.
Email: furcat_y@mail.ru

Dr.Sc. (Med.), Professor, Head of the Department of Neurology, Psychiatry and Medicinal Genetics of Medicinal Faculty, Board Member, Chief Neurologist of Southern Region of Kyrgyzstan

参考

  1. Голухова Е.З., Сливнева И.В., Рыбка М.М. и др. Структурно-функциональные изменения правого желудочка при COVID-19 по данным эхокардиографии. Креативная кардиология. 2020; 14(3): 206-223. D0I:10.24022/1997-3187-2020-14-3-206-223.
  2. Бокерия Л.А., Бокерия О.Л., Аверина И.И. и др. Использование глобальной продольной деформации левых отделов сердца в клинической практике. Оценка факторов риска, скрытой дисфункции, прогноз сердечно-сосудистой патологии. Бюллетень НЦССХ им. А.Н. Бакулева РАМН. Сердечно-сосудистые заболевания. 2020; 21(4): 372-379. D0I:10.24022/1810-0694-2020-21-4-372-379.
  3. Бокерия О.Л., Хубулова Л.Н. Женщины с фибрилляцией предсердий. Анналы аритмологии. 2019; 16(1): 15-21. doi: 10.15275/annaritmol.2019.1.2
  4. Bokhari S.R., Mansur A., Khan Assir M.Z., et al. Echocardiographic Evaluation of Left Atrial Volume Index in Patients with Chronic Kidney Disease. Saudi J Kidney Dis Transpl. 2020; 31: 750-758. https://www.sjkdt.org/text.asp?2020/31/4/750/292308.
  5. Wang H.J., Li K.L., Li J., et al. Moderate chronic kidney disease and left atrial enlargement independently predict thromboembolic events and mortality in elderly patients with atrial fibrillation: a retrospective single-center study. Journal of International Medical Research. 2019; 47(9): 4312-4323. D0I:10.1177/0300060519858151.
  6. Turakhia M.P., Blankestijn P.J., Carrero J.J., et al. Chronic kidney disease and arrhythmias: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. European heart journal. 2018; 39(24): 2314-2325. D0I:10.1093/eurheartj/ehy060
  7. Saafan R., Khalfallah M., Elhefnawy S., Kassem H. Impact of early chronic kidney disease on left atrial function and volume. J Indian coll cardiol. 2019; 9: 181-185. D0I:10.4103/JICC.JICC 29 19.
  8. Lind A., Obayda A., Lortz J., et al. Percutaneous left atrial appendage closure for stroke prevention in patients with chronic renal disease. Archives of Medical Science. 2020. doi: 10.5114/aoms.2020.92987.
  9. Randhawa M.S., Vishwanath R., Rai M.P., et al. Association between use of warfarin for atrial fibrillation and outcomes among patients with end-stage renal disease: a systematic review and meta-analysis. JAMA network open. 2020; 3: 4. e202175-e202175.
  10. Chang C.H., Fan P.C., Lin Y.S., et al. Atrial fibrillation and associated outcomes in patients with peritoneal dialysis and hemodialysis: a 14-year nationwide population-based study. Journal of Nephrology. 2020; 1-10. D0I:10.1007/s40620- 020-00713-4.
  11. Levey A.S., Stevens L.A., Schmid C.H., et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 5:150 (9):604-612. D0I:10.7326/0003-4819-150-9-200905050-00006.
  12. Devereux R.B., Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977.55(4).613-618.PMTO:138494.
  13. Williams B., Mancia G., Spiering W., et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). European heart journal. 2018; 39(33): 3021-3104. D0I:10.1093/eurheartj/ehy339
  14. Франк А. Флакскампф. Практическая эхокардиография: руководство по эхокардиографии. М.: МЕДпресс-информ. 2013.
  15. Ding W.Y., Gupta D., Wong C.F., Lip G.Y. Pathophysiology of atrial fibrillation and chronic kidney disease. Cardiovascular Research. 2020. D0I:10.1093/cvr/cvaa258.
  16. Киякбаев Г.Г., Фомин В.В., Краснова Т.Н. Клинико-патогентические ассоциации при сочетании фибрилляции предсердий и хронической болезни почек. Клиническая нефрология. 2015; 5-6: 23-27.
  17. Фомин В.В., Киякбаев Г.Г. Хроническая болезнь почек и фибрилляция предсердий. Клиническая нефрология. 2010; 6: 34-38.
  18. Mozdzan M., Wierzbowska-Drabik K., Kurpesa M., et al. Echocardiographic indices of left ventricular hypertrophy and diastolic function in hypertensive patients with preserved LVEF classified as dippers and non-dippers. Arch Med Sci. 2013; 20(9): 268-275. D0I:10.5114/aoms.2013.34534
  19. Муркамилов И.Т., Сабиров И.С., Фомин В.В. и др. Цистатин С, жесткость артерий и параметры эхокардиографии у пациентов с болезнями органов дыхания. Пульмонология. 2021; 31(4): 407-417.D0I:10.18093/0869-0189-2021-31-4-407-417.
  20. Ikizler T.A., Burrowes J.D., Byham-Gray L.D., et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. American Journal of Kidney Diseases. 2020; 76(3): S1-S107. D0I:10.1053/j.ajkd.2020.05.006.
  21. Nagaraju S.P., Paramasivam G., Prabhu R.A., et al. P1310 Study of risk factors and prevalence of pulmonary hypertension in CKD 5d patients on hemodialysis. Nephrology Dialysis ransplantation. 2020; 35 (Supplement_3): gfaa142.P1310. D0I:10.1093/ndt/gfaa142.P1310.

补充文件

附件文件
动作
1. JATS XML
##common.cookie##